itraconazole has been researched along with Otomycosis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
Alves, AI; Bezerra, JD; Buonafina-Paz, MD; Leal, MC; Leite-Andrade, MC; Lima-Neto, RG; Neves, RP; Pape, PL; Robert, E; Santos, FA | 1 |
Fatahinia, M; Halvaeezadeh, M; Jalaee, GA; Mahmoudabadi, AZ | 1 |
Hsueh, PR; Jing, R; Li, XW; Li, Y; Wang, CY; Xiao, M; Xu, YC; Yang, WH; Zou, GL | 1 |
Khosravi, AR; Mansouri, P; Nikaein, D; Saffarian, Z; Vahedi, G | 1 |
1 review(s) available for itraconazole and Otomycosis
Article | Year |
---|---|
Chronic mucocutaneous candidiasis, a case study and literature review.
Topics: Biopsy; Candida albicans; Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Child, Preschool; Feces; Female; Giardia; Humans; Iron; Itraconazole; Otomycosis; Skin | 2018 |
3 other study(ies) available for itraconazole and Otomycosis
Article | Year |
---|---|
Otomycosis caused by the cryptic and emerging species
Topics: Antifungal Agents; Aspergillus; Humans; Itraconazole; Ketoconazole; Otomycosis | 2022 |
Aspergillus welwitschiae; an otomycosis predominant agent, new epidemiological and antifungal susceptibility data from Iran.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus niger; Calmodulin; Female; Humans; Iran; Itraconazole; Male; Microbial Sensitivity Tests; Nystatin; Otomycosis; Voriconazole | 2023 |
Species identification and antifungal susceptibility testing of Aspergillus strains isolated from patients with otomycosis in northern China.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Humans; Itraconazole; Microbial Sensitivity Tests; Otomycosis; Voriconazole | 2022 |